ETON Logo

Eton Pharmaceuticals, Inc. (ETON) 

NASDAQ$11.97+0.12 (1.01%)
Market Cap
$317.79M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
137 of 893
Rank in Industry
90 of 513

ETON Insider Trading Activity

ETON Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,018,826
6
100
Sells
$0
0
0

Related Transactions

Opaleye Management Inc.10 percent owner
6
$1.02M
0
$0
$1.02M

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically â€¦

Insider Activity of Eton Pharmaceuticals, Inc.

Over the last 12 months, insiders at Eton Pharmaceuticals, Inc. have bought $1.02M and sold $0 worth of Eton Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Eton Pharmaceuticals, Inc. have bought $983,754 and sold $20.77M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $1.02M.

The last purchase of 10,000 shares for transaction amount of $79,814 was made by Opaleye Management Inc. (10 percent owner) on 2024‑10‑23.

List of Insider Buy and Sell Transactions, Eton Pharmaceuticals, Inc.

2024-10-23PurchaseOpaleye Management Inc.10 percent owner
10,000
0.0782%
$7.98
$79,814
+64.21%
2024-10-08PurchaseOpaleye Management Inc.10 percent owner
33,970
0.2339%
$7.03
$238,782
+75.68%
2024-10-07PurchaseOpaleye Management Inc.10 percent owner
11,248
0.0796%
$7.22
$81,250
+77.53%
2024-10-04PurchaseOpaleye Management Inc.10 percent owner
16,852
0.1118%
$6.77
$114,105
+84.57%
2024-09-11PurchaseOpaleye Management Inc.10 percent owner
50,000
0.2326%
$4.75
$237,500
+160.54%
2024-09-10PurchaseOpaleye Management Inc.10 percent owner
57,500
0.2619%
$4.65
$267,375
+160.67%
2022-09-22PurchaseBRYNJELSEN SEANChief Executive Officer
10,000
0.0382%
$2.10
$21,042
+61.06%
2021-11-17SaleOpaleye Management Inc.10 percent owner
25,000
0.1%
$4.67
$116,713
-31.32%
2021-11-16SaleOpaleye Management Inc.10 percent owner
12,438
0.0495%
$4.86
$60,472
-34.12%
2021-11-15SaleOpaleye Management Inc.10 percent owner
3,000
0.0112%
$4.80
$14,405
-37.28%
2021-11-08SaleOpaleye Management Inc.10 percent owner
52,661
0.2268%
$6.10
$321,285
-41.81%
2021-11-05SaleOpaleye Management Inc.10 percent owner
167,701
0.6665%
$6.30
$1.06M
-46.74%
2021-11-04SaleOpaleye Management Inc.10 percent owner
85,700
0.3409%
$6.44
$551,651
-47.20%
2021-11-03SaleOpaleye Management Inc.10 percent owner
116,500
0.4622%
$6.53
$760,850
-47.32%
2021-10-12SaleOpaleye Management Inc.10 percent owner
87,307
0.3414%
$5.06
$441,485
-28.85%
2021-10-11SaleOpaleye Management Inc.10 percent owner
34,101
0.136%
$5.01
$170,716
-26.61%
2021-10-08SaleOpaleye Management Inc.10 percent owner
43,692
0.1737%
$5.00
$218,469
-26.45%
2021-08-20PurchaseBRYNJELSEN SEANPresident & CEO
10,000
0.0388%
$4.32
$43,200
-12.02%
2021-08-20PurchaseTroutman William WilsonCFO, Treasurer & Secretary
5,000
0.0199%
$4.43
$22,150
-12.02%
2021-08-06SaleOpaleye Management Inc.10 percent owner
345,000
1.358%
$5.84
$2.01M
-32.88%
Total: 39
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Opaleye Management Inc.10 percent owner
2770000
10.3291%
$32.82M717
<0.0001%
BRYNJELSEN SEANChief Executive Officer
1040000
3.8781%
$12.32M70
<0.0001%
CASAMENTO CHARLES Jdirector
71920
0.2682%
$852,252.0020
+1.97%
RIEDEL NORBERT Gdirector
59745
0.2228%
$707,978.2510
+7.11%
MAIER PAUL Vdirector
59745
0.2228%
$707,978.2510
+7.11%
Troutman William WilsonCFO, Treasurer & Secretary
23027
0.0859%
$272,869.9520
<0.0001%
BAUM MARK Ldirector
10000
0.0373%
$118,500.0010
+7.11%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$24,384,691
42
-30.27%
$306.51M
$109,415,500
33
18.13%
$298.57M
$73,401,597
25
46.98%
$307.9M
$26,923,982
20
-17.22%
$347M
$100,566,697
18
-5.10%
$317.53M

ETON Institutional Investors: Active Positions

Increased Positions54+150%4M+44.71%
Decreased Positions15-41.67%628,671-6.6%
New Positions27New2MNew
Sold Out Positions4Sold Out24,525Sold Out
Total Postitions75+108.33%13M+38.11%

ETON Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Opaleye Management Inc.$33,740.0010.56%2.85M+72,070+2.59%2024-12-31
Ecor1 Capital, Llc$21,644.006.78%1.83M+1M+223.21%2024-12-31
Nantahala Capital Management, Llc$13,232.004.14%1.12M+119,750+11.99%2024-12-31
Vanguard Group Inc$12,584.003.94%1.06M+36,019+3.5%2024-12-31
Westside Investment Management, Inc.$6,805.002.13%575,222-43,453-7.02%2024-12-31
Mink Brook Asset Management Llc$5,392.001.69%455,805+455,805New2024-12-31
Cannell Capital Llc$4,511.001.41%381,323+381,323New2024-12-31
Blackrock, Inc.$3,758.001.18%317,625+32,770+11.5%2024-12-31
Parkman Healthcare Partners Llc$3,276.001.03%276,890+16,664+6.4%2024-12-31
Geode Capital Management, Llc$3,178.001%268,646-4,050-1.49%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.